Efficacy and Safety of Replacing Lenalidomide with Pomalidomide for Patients with Multiple Myeloma Refractory to a Lenalidomide-Containing Combination Regimen
- PMID: 35934183
- DOI: 10.1016/j.exphem.2022.07.303
Efficacy and Safety of Replacing Lenalidomide with Pomalidomide for Patients with Multiple Myeloma Refractory to a Lenalidomide-Containing Combination Regimen
Conflict of interest statement
Conflict of Interest Disclosure James R. Berenson received consultant fees, speakers’ bureau honoraria, and research funding from Bristol Myers Squibb.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical